Impairment of the Stromal SDF-1-Mediated Hematopoietic Support By GDF-11 in MDS Is Rescued By Luspatercept
Manja Wobus(Heidelberg University), Uwe Platzbecker(National Center for Tumor Diseases), Martin Bornhäuser(Technische Universität Dresden), Martina Rauner(Technische Universität Dresden), Anna Mies(University Hospital Carl Gustav Carus), Susann Winter(University Hospital Carl Gustav Carus), Lorenz C. Hofbauer(Technische Universität Dresden), Nandini Asokan(University Hospital Carl Gustav Carus), Uta Oelschlaegel(University Hospital Carl Gustav Carus)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|Blood|2019|655
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402